Clinical trial

Comparison of Estrogen and Methyltestosterone Combination Treatments for…

NCT00160342 · Solvay Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00160342
Title Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Official title A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women
Lead sponsor Solvay Pharmaceuticals, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Hot Flushes, Menopause, Postmenopause
Intervention type Drug
Interventions Esterified Estrogens (EE) and Methyltestosterone (MT)
Enrollment 1,251
Start date Jun 1, 2005
Primary completion Sep 1, 2007
Completion Sep 1, 2007
First posted Sep 12, 2005
Last update posted Aug 15, 2008
Countries Canada, Russia, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies